Quick Takeaways
- Michael Thomas Henderson has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $92,989,176.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Michael Thomas Henderson and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | Chief Executive Officer, Director | $87,465,593 | -$10,153,009 | -10% | 11 Mar 2026 |
| SYRE | Spyre Therapeutics, Inc. | Director | $5,523,583 | 21 Jan 2026 | ||
| ARYD | ARYA Sciences Acquisition Corp IV | Director | 31 Jul 2024 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|